Alnylam Pharmaceuticals
ALNY
#692
Rank
$36.96 B
Marketcap
$276.83
Share price
-2.08%
Change (1 day)
-10.33%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Net assets

Net assets on the balance sheet as of March 2026 : $1.07 Billion USD

According to Alnylam Pharmaceuticals 's latest financial reports the company has $1.07 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Alnylam Pharmaceuticals - Net assets on balance sheet (from 2003 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$$0.78 B1076.33%
2024-12-31$$67.08 M-130.41%
2023-12-31$-$0.23 Billion39.45%
2022-12-31$-$0.16 Billion-126.9%
2021-12-31$$0.58 B-42.12%
2020-12-31$$1.01 B-29.36%
2019-12-31$$1.43 B10.5%
2018-12-31$$1.30 B-26.29%
2017-12-31$$1.76 B91.96%
2016-12-31$$0.92 B-27.24%
2015-12-31$$1.26 B35.08%
2014-12-31$$0.93 B246.32%
2013-12-31$$0.27 B101.67%
2012-12-31$$0.13 B13.61%
2011-12-31$$0.11 B-25.43%
2010-12-31$$0.15 B-11.09%
2009-12-31$$0.17 B-11.95%
2008-12-31$$0.20 B1.48%
2007-12-31$$0.19 B-1%
2006-12-31$$0.20 B225.63%
2005-12-31$$61.77 M33.89%
2004-12-31$$46.14 M-272.77%
2003-12-31$-$26.71 Million474.84%
2002-12-31$-$4.65 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Novartis
NVS
$38.92 B 3,519.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
$84.65 B 7,772.31%๐Ÿ‡ซ๐Ÿ‡ท France
Regeneron Pharmaceuticals
REGN
$31.42 B 2,822.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
$1.50 B 39.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
$69.02 M-93.58%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
$1.26 B 17.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$8.23 B 665.50%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Arrowhead Pharmaceuticals
ARWR
$0.59 B-44.31%๐Ÿ‡บ๐Ÿ‡ธ USA